Drug intelligence / Profile preview

N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is an experimental small molecule belonging to the class of quinazolinamines, which are heterocyclic aromatic compounds containing a quinazoline core with amine substituents. It has a molecular formula of C25H29N5O2 and a molecular weight of 431.53 g/mol. The drug is referenced in chemical databases such as DrugBank (DB08351), PubChem (CID 24963046), and ChEMBL (CHEMBL494072). There is no evidence that it has been approved for any indication or that it has reached advanced clinical development stages. Its mechanism of action, biological targets, therapeutic indications, developer(s), and manufacturer(s) are not specified in available public sources[1][6][2].

Other names: N-cyclopropyl-4-methyl-3-(2-{[2-(morpholin-4-yl)ethyl]amino}quinazolin-6-yl)benzamideN-cyclopropyl-4-methyl-3-(2-{[2-(morpholinylethyl)amino]quinazolin}-6-y1)-benzamide

Beyond the preview

Go deeper on N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide.

Explore the full profile